Abstract
Methods The 30 rats were randomly divided into normal control group, the non-treatment group of liver fibrosis model and the treatment group of liver fibrosis model. Each group of rats are take the following operation: Western blotting test OPN protein expression after eitht weeks。The PCR detection of TGF-β1 mRNA expression level. Results This study showed that the treatment group of liver fibrosis model of HA, LN, PCIII, CIV radioimmunoassay were higher than the treatment group have significant differences (P＜0.01), and the differences were statistically significant than the non-treatment group of liver fibrosis model at the same time（P＜0.05）. The non-treatment group of liver fibrosis model of HA(Hyaluronic acid), LN(Laminin), PCIII(Procollagen type III), CIV radioimmunoassay showed significant differences compared to the treatment group of liver fibrosis model （P＜0.01）. Using the treatment group of liver fibrosis model of OPN protein expression level, differences were found inthe normal group（t=2.236, P＜0.05), and the differences were statistically significant than the non-treatment group of liver fibrosis model at the same time (t=1.024, P＜0.01). Using the treatment group of liver fibrosis model of TGF-β1 mRNA expression level of numerical difference compared with normal group (t=2.245, P＜0.05), and compared with the non-treatment group of liver fibrosis model had significant difference (t=1.024, P＜0.01). Conclusions The P. scandens granule could inhibit the OPN protein expression, inhibition of TGF-β1 mRNA expression, slow down the progress of liver fibrosis. Through the experiments, it showed that OPN associated with TGF-β1 regulation of signaling pathway and the specific signaling pathways regulating needs further research.
Publication Date
8-28-2018
First Page
16
Last Page
18
DOI
10.13652/j.issn.1003-5788.2018.08.004
Recommended Citation
Yong, YUAN
(2018)
"Experimental study on the expression level of OPN and TGF-β1 in rat liver fibrosis model with tuber granule intervention,"
Food and Machinery: Vol. 34:
Iss.
8, Article 4.
DOI: 10.13652/j.issn.1003-5788.2018.08.004
Available at:
https://www.ifoodmm.cn/journal/vol34/iss8/4
References
[1] 吴孟超, 李梦东. 实用肝病学[M]. 北京: 人民卫生出版社, 2011: 485-488.
[2] 贺佩, 胡君健, 何永康, 等. 四种单味中药及其复方对小鼠血吸虫病肝纤维化Ⅰ、Ⅲ型胶原及TGF-β1表达的影响[J]. 热带病与寄生虫学, 2016, 14(1): 25-27.
[3] 上海中医药大学中医文献研究所. 申江医翠续集: 内科名家姜春华学术经验集[M]. 上海: 上海中医药大学出版社, 2003: 147-148.
[4] 廖建良, 单沛贤. 乌厥、鸡屎藤提取物的抑菌活性研究[J]. 惠州学院学报: 自然科学版, 2016, 36(3): 9-13.
[5] 韩德承. 活血止痛鸡屎藤[J]. 中国中医药报: 农村与社区版, 2012, 8(30): 5.
[6] 陶翠玲, 金春英, 赵艳波, 等. 肝纤康治疗慢性病毒性肝炎肝纤维化痰瘀互结证的临床研究[J]. 中医药学报, 2003, 31(4): 6.
[7] ARAI M, YOKOSUKA O, KANDA T, et a1. Serum osteopontinl evels inpatients with acutel iver dysfunction[J]. Scand J Gastroenterol, 2006, 41(1): 102-110.
[8] 刘茂希, 杨继武, 张凤. 免疫性大鼠肝纤维化肝组织中骨桥蛋白的表达[J]. 军医进修学院学报, 2012, 33(2): 183-184.
[9] 张斌, 赵莹, 陈建杰, 等. 肝纤维化时肝脏OPN和PAI-1的表达变化[J]. 中国病理生理杂志, 2010, 26(7): 1 407-1 409.
[10] 黄大建, 赵永忠, 卢青, 等. 转化生长因子β1和骨桥蛋白在肝纤维化大鼠肝组织的表达及荔枝核总黄酮的干预[J]. 实用医学杂志, 2013, 29(22): 3 646-3 649.
[11] TANIGUCHI H, KATO N, OTSUKA M, et al. Hepatitis C virus core protein upre gulates transforming growth factor-beta1 transcription[J]. Journal of Medical Virology, 2004, 72: 52.